Pinteaux E - Search Results

1

Characterization of a conditional interleukin-1 receptor 1 mouse mutant using the Cre/LoxP system.

Abdulaal WH, Walker CR, Costello R, Redondo-Castro E, Mufazalov IA, Papaemmanouil A, Rothwell NJ, Allan SM, Waisman A, Pinteaux E, Müller W. Abdulaal WH, et al. Among authors: pinteaux e. Eur J Immunol. 2016 Apr;46(4):912-8. doi: 10.1002/eji.201546075. Epub 2016 Jan 18. Eur J Immunol. 2016. PMID: 26692072 Free PMC article.

2

IL-1 beta signalling in glial cells in wildtype and IL-1RI deficient mice.

Parker LC, Luheshi GN, Rothwell NJ, Pinteaux E. Parker LC, et al. Among authors: pinteaux e. Br J Pharmacol. 2002 May;136(2):312-20. doi: 10.1038/sj.bjp.0704715. Br J Pharmacol. 2002. PMID: 12010781 Free PMC article.

3

Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells.

Pinteaux E, Parker LC, Rothwell NJ, Luheshi GN. Pinteaux E, et al. J Neurochem. 2002 Nov;83(4):754-63. doi: 10.1046/j.1471-4159.2002.01184.x. J Neurochem. 2002. PMID: 12421347 Free article.

4

IL-1Rrp2 expression and IL-1F9 (IL-1H1) actions in brain cells.

Berglöf E, Andre R, Renshaw BR, Allan SM, Lawrence CB, Rothwell NJ, Pinteaux E. Berglöf E, et al. Among authors: pinteaux e. J Neuroimmunol. 2003 Jun;139(1-2):36-43. doi: 10.1016/s0165-5728(03)00130-9. J Neuroimmunol. 2003. PMID: 12799018

5

The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain?

Boutin H, Kimber I, Rothwell NJ, Pinteaux E. Boutin H, et al. Among authors: pinteaux e. Mol Neurobiol. 2003 Jun;27(3):239-48. doi: 10.1385/MN:27:3:239. Mol Neurobiol. 2003. PMID: 12845150 Review.

6

Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia.

Molina-Holgado F, Pinteaux E, Moore JD, Molina-Holgado E, Guaza C, Gibson RM, Rothwell NJ. Molina-Holgado F, et al. Among authors: pinteaux e. J Neurosci. 2003 Jul 23;23(16):6470-4. doi: 10.1523/JNEUROSCI.23-16-06470.2003. J Neurosci. 2003. PMID: 12878687 Free PMC article.

7

The interleukin-1 system: an attractive and viable therapeutic target in neurodegenerative disease.

Allan SM, Pinteaux E. Allan SM, et al. Among authors: pinteaux e. Curr Drug Targets CNS Neurol Disord. 2003 Oct;2(5):293-302. doi: 10.2174/1568007033482742. Curr Drug Targets CNS Neurol Disord. 2003. PMID: 14529361 Review.

8

Identification of a truncated IL-18R beta mRNA: a putative regulator of IL-18 expressed in rat brain.

Andre R, Wheeler RD, Collins PD, Luheshi GN, Pickering-Brown S, Kimber I, Rothwell NJ, Pinteaux E. Andre R, et al. Among authors: pinteaux e. J Neuroimmunol. 2003 Dec;145(1-2):40-5. doi: 10.1016/j.jneuroim.2003.09.005. J Neuroimmunol. 2003. PMID: 14644029

9

Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling.

Molina-Holgado F, Pinteaux E, Heenan L, Moore JD, Rothwell NJ, Gibson RM. Molina-Holgado F, et al. Among authors: pinteaux e. Mol Cell Neurosci. 2005 Jan;28(1):189-94. doi: 10.1016/j.mcn.2004.09.004. Mol Cell Neurosci. 2005. PMID: 15607953

10

Differential actions of IL-1 alpha and IL-1 beta in glial cells share common IL-1 signalling pathways.

Andre R, Pinteaux E, Kimber I, Rothwell NJ. Andre R, et al. Among authors: pinteaux e. Neuroreport. 2005 Feb 8;16(2):153-7. doi: 10.1097/00001756-200502080-00017. Neuroreport. 2005. PMID: 15671867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters